CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$5.00

Daily low

$4.62

Price at open

$4.71

52 Week High

$9.08

52 Week Low

$4.25

Market cap

342.1M

Dividend yield

0.00%

Volume

1.5M

Avg. volume

1.7M

P/E ratio

-6.66

Candel Therapeutics News